Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Classic Hodgkin Lymphoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Lymphoma
Hodgkin Lymphoma
Classic Hodgkin Lymphoma

Hematologic Malignancy

Classic Hodgkin Lymphoma

CI-CAN-00002375CHLExplore in graph →

Hematologic41 active trials3 approved drugs

NCIt: C7164
OncoTree: CHL
UMLS CUI: C1333064

Overview
Statistics
Survival
Genomics1
Variants & evidence
Drugs
Trials114
Research
Rankings
Sources & provenance

Data completeness4 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (data present)
Evidence (no data yet)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A category of Hodgkin lymphomas that includes the following four histologic subtypes: lymphocyte-rich, nodular sclerosis, mixed cellularity, and lymphocyte-depleted classic Hodgkin lymphoma. The vast majority of Hodgkin lymphomas belong to this category.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Hodgkin LymphomaHematologic Malignancy

oncotree

Hodgkin LymphomaHematologic Malignancy

Children (10)

ncit

Adult Classic Hodgkin Lymphoma4 sub
Childhood Classic Hodgkin Lymphoma4 sub
Lymphocyte-Depleted Classic Hodgkin Lymphoma3 sub
Lymphocyte-Rich Classic Hodgkin Lymphoma2 sub
Mixed Cellularity Classic Hodgkin Lymphoma3 sub
Nodular Sclerosis Classic Hodgkin Lymphoma7 sub

oncotree

Anatomy

Anatomical sites

Hematopoietic and Lymphatic SystemC35813

Record

Identity

CancerIndex ID: CI-CAN-00002375
Entity type: Hematologic Malignancy
Malignant: Yes
Solid / hematologic: Hematologic
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 5
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

Lymphocyte-Depleted Classical Hodgkin Lymphoma
Lymphocyte-Rich Classical Hodgkin Lymphoma
Mixed Cellularity Classical Hodgkin Lymphoma
Nodular Sclerosis Classical Hodgkin Lymphoma

25 descendants in total; counters on this page aggregate over all of them.

114 / 41

Publications (all / 5y)

3,300 / 1,452

Evidence items

0

Genes / variants

3 / 0

Drugs (any / approved)

0 / 3

Genomic cohorts

1

Epidemiology / survival obs.

0 / 0

Data updated 16 minutes agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (1)

Classical Hodgkin Lymphomasynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

US deaths909countUnited States · 2024 · both sexes · all agescdc-wonderObservedrank #26 of 31 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Hodgkin Lymphoma (registry level) — open Hodgkin Lymphoma
US new cases8,858countUnited States · 2023 · both sexes · all agescdc-uscsObservedrank #24 of 32 (USA · both sexes · all ages · 2023 · top-level cancers)figures shown for Hodgkin Lymphoma (registry level) — open Hodgkin Lymphoma
US age-standardized mortality0.2per 100,000United States · 2024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderObservedrank #21 of 23 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Hodgkin Lymphoma (registry level) — open Hodgkin Lymphoma
Active trials41countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #320 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials17countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #347 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items0countaccepted CIViC items · entity + descendantscivicComputednot in a current ranking snapshot
Publications, last 12 months346countPubMed records · stored query · 12-month windowpubmedComputedrank #187 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts1countopen GDC projects · entity + descendantsgdcComputedrank #228 of 296 (World · both sexes · all ages · latest · all malignant entities)

Data updated 16 minutes agoSource updated unknownregistry figures: cdc-uscs · latest year available per metric · counters aggregate over descendants